These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37385351)

  • 41. Optimal physical performance in athletes: key roles of dopamine in a specific neurotransmitter/hormonal mechanism.
    Gilbert C
    Mech Ageing Dev; 1995 Oct; 84(2):83-102. PubMed ID: 8788237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
    Kondziella D; Brenner E; Eyjolfsson EM; Sonnewald U
    Neurochem Int; 2007 Jan; 50(2):291-301. PubMed ID: 17084946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholinergic-monoaminergic interaction in the pathophysiology of the affective disorders?
    Dilsaver SC
    Int Clin Psychopharmacol; 1986 Jul; 1(3):181-98. PubMed ID: 2435781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
    Kalia LV; Brotchie JM; Fox SH
    Mov Disord; 2013 Feb; 28(2):131-44. PubMed ID: 23225267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurotoxicological evaluation of microcystin-LR exposure at environmental relevant concentrations on nematode Caenorhabditis elegans.
    Ju J; Ruan Q; Li X; Liu R; Li Y; Pu Y; Yin L; Wang D
    Environ Sci Pollut Res Int; 2013 Mar; 20(3):1823-30. PubMed ID: 22956115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocytosis of GABA receptor: Signaling in nervous system.
    Sharma P; Sharma BS; Raval H; Singh V
    Prog Mol Biol Transl Sci; 2023; 196():125-139. PubMed ID: 36813355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurotransmitters in the regulation of neuronal cytoarchitecture.
    Mattson MP
    Brain Res; 1988; 472(2):179-212. PubMed ID: 2898278
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoamine neurotransmitter disorders--clinical advances and future perspectives.
    Ng J; Papandreou A; Heales SJ; Kurian MA
    Nat Rev Neurol; 2015 Oct; 11(10):567-84. PubMed ID: 26392380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Reliable Method Based on Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Quantification of Neurotransmitters in
    Weishaupt AK; Kubens L; Ruecker L; Schwerdtle T; Aschner M; Bornhorst J
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurotransmitter signaling in white matter.
    Butt AM; Fern RF; Matute C
    Glia; 2014 Nov; 62(11):1762-79. PubMed ID: 24753049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Corelease of acetylcholine and GABA from cholinergic forebrain neurons.
    Saunders A; Granger AJ; Sabatini BL
    Elife; 2015 Feb; 4():. PubMed ID: 25723967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Top 5 Neurotransmitters from a Clinical Neurologist's Perspective.
    Kondziella D
    Neurochem Res; 2017 Jun; 42(6):1767-1771. PubMed ID: 27822666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presynaptic inhibition of the release of multiple major central nervous system neurotransmitter types by the inhaled anaesthetic isoflurane.
    Westphalen RI; Desai KM; Hemmings HC
    Br J Anaesth; 2013 Apr; 110(4):592-9. PubMed ID: 23213036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurotransmitters in central respiratory control.
    Burton MD; Kazemi H
    Respir Physiol; 2000 Sep; 122(2-3):111-21. PubMed ID: 10967338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacology of molluscan neurons.
    Rózsa KS
    Prog Neurobiol; 1984; 23(1-2):79-150. PubMed ID: 6151715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analytical methods to monitor dopamine metabolism in plasma: Moving forward with improved diagnosis and treatment of neurological disorders.
    Abrantes Dias AS; Amaral Pinto JC; Magalhães M; Mendes VM; Manadas B
    J Pharm Biomed Anal; 2020 Aug; 187():113323. PubMed ID: 32470692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories.
    Caldecott-Hazard S; Morgan DG; DeLeon-Jones F; Overstreet DH; Janowsky D
    Synapse; 1991 Dec; 9(4):251-301. PubMed ID: 1685032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Neurotransmitters, calcium signalling and neuronal communication].
    Eguiagaray JG; Egea J; Bravo-Cordero JJ; García AG
    Neurocirugia (Astur); 2004 Apr; 15(2):109-18. PubMed ID: 15159788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral Dopamine Neurotrophic Factor Regulates Multiple Neuronal Subtypes and Behavior.
    Chen YC; Baronio D; Semenova S; Abdurakhmanova S; Panula P
    J Neurosci; 2020 Aug; 40(32):6146-6164. PubMed ID: 32631936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Homeodomain-interacting protein kinase maintains neuronal homeostasis during normal
    Lazaro-Pena MI; Cornwell AB; Diaz-Balzac CA; Das R; Ward ZC; Macoretta N; Thakar J; Samuelson AV
    Elife; 2023 Jun; 12():. PubMed ID: 37338980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.